skip to content

Cambridge Biosciences DTP PhD Programme

 

Congratulations to Celia Alda-Catalinas, 2015 cohort PhD student in the BBSRC DTP Programme, for publishing the paper ‘scNMT-seq enables joint profiling of chromatin accessibility DNA methylation and transcription in single cellsin Nature Communications.

Abstract

Parallel single-cell sequencing protocols represent powerful methods for investigating regulatory relationships, including epigenome-transcriptome interactions. Here, we report a single-cell method for parallel chromatin accessibility, DNA methylation and transcriptome profiling. scNMT-seq (single-cell nucleosome, methylation and transcription sequencing) uses a GpC methyltransferase to label open chromatin followed by bisulfite and RNA sequencing. We validate scNMT-seq by applying it to differentiating mouse embryonic stem cells, finding links between all three molecular layers and revealing dynamic coupling between epigenomic layers during differentiation.

To read the full publication, please click here.

Latest news

PIPS Symposium 2025: Connecting Students with Future Opportunities

1 April 2025

Our annual PIPS Symposium took place on Friday, 28 March, at the Babraham Campus, bringing together students and host organisations for a half-day of networking, insights, and career development opportunities. The event is designed to support current students who have yet to complete their PIPS by connecting them with potential host organisations across various sectors.

Cambridge Researchers Identify Genes Linked to Obesity in Both Dogs and Humans

17 March 2025

Dr. Natalie Wallis and Dr. Alyce McClellan, both alumnae of the Cambridge Biosciences DTP programme (2019 cohort), are joint first authors on a groundbreaking study published in Science.

Exploring the Role of RAMP Proteins in Obesity and Diabetes

21 November 2024

A BBSRC DTP student, Milena Malcharek, has achieved a significant milestone by publishing her first paper in the prestigious Journal of Molecular Endocrinology. Her review investigates the critical role of receptor activity-modifying proteins (RAMPs) in the pathophysiology of obesity and diabetes mellitus.